2021
DOI: 10.3390/ijms221910732
|View full text |Cite
|
Sign up to set email alerts
|

Changes in Maternal Platelet Physiology during Gestation and Their Interaction with Trophoblasts

Abstract: Upon activation, maternal platelets provide a source of proinflammatory mediators in the intervillous space of the placenta. Therefore, platelet-derived factors may interfere with different trophoblast subtypes of the developing human placenta and might cause altered hormone secretion and placental dysfunction later on in pregnancy. Increased platelet activation, and the subsequent occurrence of placental fibrinoid deposition, are linked to placenta pathologies such as preeclampsia. The composition and release… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
6
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(10 citation statements)
references
References 124 publications
1
6
0
1
Order By: Relevance
“…Platelet count had a significant but negative correlation with the duration of hypertension illness, while MPV showed a positive and significant correlation [ 49 ]. Increased platelet activation, and the subsequent occurrence of placental fibrinoid deposition, are linked to placenta pathologies such as preeclampsia [ 50 ].…”
Section: Discussionmentioning
confidence: 99%
“…Platelet count had a significant but negative correlation with the duration of hypertension illness, while MPV showed a positive and significant correlation [ 49 ]. Increased platelet activation, and the subsequent occurrence of placental fibrinoid deposition, are linked to placenta pathologies such as preeclampsia [ 50 ].…”
Section: Discussionmentioning
confidence: 99%
“…The second is about the development of immunotherapies. It is well known that excessive inflammatory response is a key driver of preeclampsia, and alterations in the number and activity of immune cells may prevent or inhibit the development of the disease, for example, researchers have now proposed CAR T-cell therapy to ameliorate the development of preeclampsia from theory ( 76 ), however, for the exact corellation between impaired immune cells and preeclampsia, the underlying mechanism, the validation of preclinical rodent models, and the feasibility of immunotherapies still need to be further explored and validated. Finally, we still need to explore markers with high sensitivity and specificity and the exact mechanism, which are important for the future exploration of the optimal timing of intervention, prevention and development of therapeutic approaches for HDP.…”
Section: Discussionmentioning
confidence: 99%
“…Aunque se desconoce la etiología de la preeclampsia, se considera que la alteración de la placentación y de la tolerancia inmune, además de la acentuada respuesta inflamatoria vascular materna, son responsables de su aparición (13) . El material fibrinoide y las células espumosas ubicadas alrededor de las arterias espirales causan disminución del flujo sanguíneo, lo cual conduce a hipoxia (14) . Se ha descrito aumento de la estimulación de la producción de eritropoyetina secundaria a la hipoxia placentaria subyacente las preeclámpticas (3) .…”
Section: Discussionunclassified